Professor Janet Berrington Saweta Garg Professor Christopher Stewart Professor Chris Lamb Dr Jeremy Palmer et al. | Powdered human milk‐derived versus bovinemilk‐derived breastmilk fortification: A multi‐centrepreterm randomised controlled trial | 2025 |
|
Raya Vinogradov Dr Oisín Kavanagh Dr Jeremy Palmer Dr Emma Curtis Professor Farhad Kamali et al. | A randomized crossover design study comparing the pharmacokinetics and pharmacodynamics of 2 single doses of oral aspirin (75 mg v 150 mg) in pregnant women at risk of preeclampsia: implications on assessing aspirin response and patient adherence to therapy | 2024 |
|
Dr Min Cao Dr Alison Day Dr Martin Galler Heather Latimer Tom Foy et al. | A peroxiredoxin-P38 MAPK scaffold increases MAPK activity by MAP3K-independent mechanisms | 2023 |
|
Lucy Gee Dr Ben Barron-Millar Dr Marco Zaki Dr Saimir Luli Rachel Burgoyne et al. | Anti–Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct–Ligated Mice | 2023 |
|
Dr Olivier Govaere Dr Rebecca Darlay Dr Julien Peltier Dr Jeremy Palmer Dr Massimo Younes et al. | Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease | 2022 |
|
Dr Aaron Wetten Dr Laura Ogle Dr George Mells Dr Vinod Hegade Dr Laura Jopson et al. | Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis? | 2022 |
|
Dr Sam Tingle Dr Emily Thompson Lucy Bates Dr Ibrahim Ibrahim Dr Olivier Govaere et al. | Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2,4-dinitrophenol delivery to steatotic human livers | 2022 |
|
Dr Claire Granger Professor Chris Lamb Professor Nicholas Embleton Lauren Beck Andrea Masi et al. | sIgA in preterm infants: determination of normal values in breast milk and stool | 2022 |
|
Professor David Jones Dr Aaron Wetten Dr Ben Barron-Millar Dr Laura Ogle Dr George Mells et al. | The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study | 2022 |
|
Dr Claire Granger Professor Nicholas Embleton Dr Jeremy Palmer Professor Chris Lamb Professor Janet Berrington et al. | Maternal breastmilk, infant gut microbiome and the impact on preterm infant health | 2021 |
|
Dr Alistair Leitch Dr Ibrahim Ibrahim Dr Tarek Mamdouh Abdelghany Dr Alex Charlton Clair Roper et al. | The methylimidazolium ionic liquid M8OI is detectable in human sera and is subject to biliary excretion in perfused human liver | 2021 |
|
Dr Ben Barron-Millar Dr Laura Ogle Emeritus Professor John Kirby Dr Jeremy Palmer Dr Laura Jopson et al. | The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis | 2021 |
|
Professor Quentin Anstee Dr Rebecca Darlay Dr Simon Cockell Dr Olivier Govaere Dr Dina Tiniakos et al. | Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort | 2020 |
|
Dr Alistair Leitch Dr Tarek Mamdouh Abdelghany Dr Phillip Probert Dr Stephanie Meyer Dr Jeremy Palmer et al. | The toxicity of the methylimidazolium ionic liquids, with a focus on M8OI and hepatic effects | 2020 |
|
Dr Olivier Govaere Dr Simon Cockell Dr Dina Tiniakos Dr Rachel Queen Dr Massimo Younes et al. | Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis | 2020 |
|
Dr Phillip Probert Dr Alistair Leitch Dr Michael Dunn Dr Stephanie Meyer Dr Jeremy Palmer et al. | Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis | 2018 |
|
Dr Emma Scott Dr Jeremy Palmer Professor Quentin Anstee
| Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD | 2017 |
|
Dr Phillip Probert Dr Jeremy Palmer Dr Aimen Amer Steven White Professor David Jones et al. | Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1′-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism | 2016 |
|
Dr Jess Dyson Dr Jeremy Palmer Dr Lin Lee Wong Dr Stuart Kendrick Professor David Jones et al. | Understanding the importance of pro- and anti-inflammatory cytokines in autoimmune hepatitis | 2016 |
|
Dr Edwin Wong Dr Jeremy Palmer Professor Neil Sheerin Dr Isabel Pappworth
| FH1-5(18-20) ameliorates experimental C3 glomerulopathy; generation and testing of a murine version for further pre-clinical experiments | 2015 |
|
Dr Jeremy Palmer Dr Yang-Lin Liu Professor Chris Day Professor Ann Daly Professor Quentin Anstee et al. | Mechanistic Study of TM6SF2 in NAFLD pathogenesis: Stably transfected Huh7 cells over-expressing the TM6SF2 E167K variant exhibit greater levels of oxidative stress | 2015 |
|
Dr Laura Jopson Emerita Professor Julia Newton Dr Jeremy Palmer Achilleas FLOUDAS Professor John Isaacs et al. | RITPBC: B-Cell Depleting Therapy (rituximab) as a treatment for fatigue in Primary Biliary Cirrhosis: study protocol for a randomised controlled trial | 2015 |
|
Dr Laura Jopson Emerita Professor Julia Newton Denise Howel Dr Jeremy Palmer Professor John Isaacs et al. | RITPBC: B-cell depleting therapy (RITUXIMAB) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial | 2015 |
|
Dr Jeremy Palmer Professor David Jones Dr Jess Dyson Emeritus Professor John Kirby
| Understanding the Mechanisms Underpinning Treatment Non-Response in Primary Biliary Cirrhosis: A Tool for Treatment Stratification | 2014 |
|
Dr Jeremy Palmer Dr Jess Dyson Professor David Jones Emeritus Professor John Kirby
| Understanding the mechanisms underpinning treatment non-response in Primary Biliary Cirrhosis: a tool for treatment stratification | 2014 |
|
Achilleas FLOUDAS Dr Laura Jopson Dacia Jones Dr Andrew Knight Dr Jeremy Palmer et al. | Altered B cell populations and cytokine production in primary biliary cirrhosis | 2013 |
|
Greta Pells Samantha Ducker Dr Jeremy Palmer Emerita Professor Julia Newton Dacia Jones et al. | Patient Impact of Inflammation in Primary Biliary Cirrhosis (PBC): Inflammatory Cytokine Levels are Elevated but Unrelated to Fatigue Severity | 2013 |
|
Dr Jeremy Palmer Professor Farhad Kamali
| Quality of bevacizumab compounded for intravitreal administration | 2013 |
|
Dr Graeme O'Boyle Christopher Fox Dr Hannah Walden Dr Joe Willet Dr Emily Mavin et al. | Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation | 2012 |
|
Dr Jeremy Palmer Dr Andrew Knight Professor Kevin Marchbank
| A novel chimeric antigen hC3d-TTCF-hC4BP interacts with mCR2 allowing extensive testing as a novel adjuvant using murine models | 2010 |
|
Dr Stuart Kendrick Dr Graeme O'Boyle Professor Jelena Mann Dr Mujdat Zeybel Dr Jeremy Palmer et al. | Acetate, the Key Modulator of Inflammatory Responses in Acute Alcoholic Hepatitis | 2010 |
|
Dr Jeremy Palmer Dr Imran Patanwala Elsbeth Henderson Professor Chris Day Professor David Jones et al. | Allo- and auto-antibody responses in ALD as biomarkers of prognosis | 2010 |
|
Dr Stuart Kendrick Elsbeth Henderson Dr Jeremy Palmer Professor David Jones Professor Chris Day et al. | Theophylline improves steroid sensitivity in acute alcoholic hepatitis | 2010 |
|
Dr Jeremy Palmer Dr Hannah Walden Emeritus Professor John Kirby Professor David Jones
| 680: Incorporation of 6-bromohexanoic acid (6BH) into cellular pyruvate dehydrogenase complex (PDC): Further evidence for generation of an autoimmunogenic neoantigen in primary billary cirrhosis (PBC) | 2009 |
|
Dr Stuart Kendrick Dr Graeme O'Boyle Dr Jeremy Palmer Professor David Jones
| Enhanced inflammatory responses in alcoholic liver disease: is acetate the key? | 2008 |
|
Dr Jeremy Palmer Professor David Jones Emeritus Professor John Kirby
| Human Th17 cells: investigation of T cell differentiation in the presence of TGF-beta and a range of pro-inflammatory cytokines | 2008 |
|
Emerita Professor Julia Newton Dr Kieren Hollingsworth Dr Jeremy Palmer Professor Roy Taylor Professor Andrew Blamire et al. | Mitochondrial dysfunction and muscle PH abnormality post-exercise: A two-hit mechanism for fatigue pathogenesis in primary biliary cirrhosis | 2008 |
|
Dr Kieren Hollingsworth Emerita Professor Julia Newton Professor Roy Taylor Dr Claire McDonald Dr Jeremy Palmer et al. | Pilot Study of Peripheral Muscle Function in Primary Biliary Cirrhosis: Potential Implications for Fatigue Pathogenesis | 2008 |
|
Professor David Jones Dr Jeremy Palmer Professor Alastair Burt Emeritus Professor John Kirby
| The specificity of liver inflammation in mouse models of primary biliary cirrhosis | 2008 |
|
Dr Hannah Walden Emeritus Professor John Kirby Emeritus Professor Steve Yeaman Dr Joseph Gray Professor David Jones et al. | Xenobiotic Incorporation into Pyruvate Dehydrogenase Complex Can Occur Via the Exogenous Lipoylation Pathway | 2008 |
|
Dr Stuart Kendrick Dr Jeremy Palmer Professor David Jones Professor Chris Day
| Lymphocyte steroid sensitivity in severe alcoholic hepatitis | 2007 |
|
Dr Hannah Walden Dr Jeremy Palmer Emeritus Professor John Kirby Dr Stuart Kendrick Professor David Jones et al. | Substrate promiscuity in the pyruvate dehydrogenase complex (PDC) lipoylation pathway: Xenobiotic incorporation as a potential mechanism for the pathogenesis of primary biliary cirrhosis (PBC) | 2007 |
|
Professor David Jones Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby
| Adoptive transfer of self-PDC reactive T-cells into naive mice induces portal tract and bile duct changes characteristic of primary biliary cirrhosis (PBC) | 2006 |
|
Dr Amanda Greenall Katherine Martin Dr Jeremy Palmer Dr Joseph Gray Dr Simon Whitehall et al. | Hip3 interacts with the HIRA proteins Hip1 and Slm9 and is required for transcriptional silencing and accurate chromosome segregation | 2006 |
|
Anna McHugh Dr Amanda Robe Dr Jeremy Palmer Professor David Jones
| PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosis | 2006 |
|
Dr Amanda Robe Emeritus Professor John Kirby Professor David Jones Dr Jeremy Palmer
| A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse | 2005 |
|
Dr Amanda Robe Emeritus Professor John Kirby Professor David Jones Dr Jeremy Palmer
| A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse | 2005 |
|
Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones
| Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex | 2004 |
|
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones
| Breakdown of T-cell tolerance to the primary biliary cirrhosis (PBC) autoantigen pyruvate dehydrogenase complex is a B-cell driven process | 2004 |
|
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones
| Breakdown of T-cell tolerance to the primary biliary cirrhosis (PBC) autoantigen pyruvate dehydrogenase complex is a B-cell driven process | 2004 |
|
Dr Jeremy Palmer Dr Amanda Robe Professor Alastair Burt Emeritus Professor John Kirby Professor David Jones et al. | Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse | 2004 |
|
Anna McHugh Dr Jeremy Palmer Emeritus Professor Steve Yeaman Professor David Jones
| Is PDC-E3BP (protein X) a T-cell autoantigen in primary biliary cirrhosis? | 2003 |
|
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor Margaret Bassendine Professor David Jones et al. | [abstract] Characterisation of liver infiltrating T-cell antigen specificity in a mouse model of primary biliary cirrhosis (PBC) | 2002 |
|
Professor David Jones Dr Jeremy Palmer Professor Alastair Burt Dr Amanda Robe Emeritus Professor John Kirby et al. | Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex | 2002 |
|
Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones
| Breakdown of tolerance is seen to both PDC-E2 and PDC-E3BP, individual antigens in primary biliary cirrhosis, in a mouse model of PDC autoreactivity | 2002 |
|
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones
| Characterisation of liver infiltrating T-cell antigen specificity in a mouse model of primary biliary cirrhosis (PBC) | 2002 |
|
Professor David Jones Dr Jeremy Palmer Dr Amanda Robe Emeritus Professor John Kirby
| Oral tolerisation to pyruvate dehydrogenase complex as a potential therapy for primary biliary cirrhosis | 2002 |
|
Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones
| The immunology of primary biliary cirrhosis: The end of the beginning? | 2002 |
|
Dr Jeremy Palmer Emeritus Professor Steve Yeaman Professor David Jones
| Epitope specificity of anti-PDC E1 alpha antibodies in primary biliary cirrhosis (PBC) | 2001 |
|
Dr Jeremy Palmer Emeritus Professor John Kirby Emeritus Professor Steve Yeaman Professor Margaret Bassendine Professor David Jones et al. | Secretory autoantibodies in primary biliary cirrhosis (PBC) | 2000 |
|
Dr Jeremy Palmer Professor David Jones Professor Janet Quinn Anna McHugh Emeritus Professor Steve Yeaman et al. | Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis | 1999 |
|
Marian Case Professor Alastair Burt Joan Hughes Dr Jeremy Palmer Professor Margaret Bassendine et al. | Erratum to 'Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol' (Journal of Immunological Methods (1999) 223 (93-106)) | 1999 |
|
Dr Jeremy Palmer Emeritus Professor John Kirby Emeritus Professor Steve Yeaman Professor David Jones
| Persistence of secretory autoantibodies in PBC patients post-liver transplant: a potential mechanism for disease recurrence? | 1999 |
|
Dr Jeremy Palmer Emeritus Professor Steve Yeaman Professor Margaret Bassendine Professor David Jones
| T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC) | 1999 |
|
Dr Ian Brotherick Dr Brian Shenton Emeritus Professor John Kirby Dr Jeremy Palmer Emeritus Professor Steve Yeaman et al. | Production of immunosuppressive factors by a cultured tumor cell line and their effect on lymphocyte proliferation and cells cycle response | 1993 |
|